Pro- and anti-angiogenesis effects of resveratrol

In Vivo

Volumn 21, Issue 2, 2007, Pages 365-370

  Chen, Yun ^a,b   Tseng, Sheng Hong ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Anti angiogenesis; Pro Angiogenesis; Resveratrol; Review

Indexed keywords

DRUG METABOLITE; RESVERATROL; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; PLANT EXTRACT; STILBENE DERIVATIVE;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BRAIN ISCHEMIA; CANCER INHIBITION; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; GLIOMA; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIA; KIDNEY ISCHEMIA; LEWIS CARCINOMA; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; OVARY CANCER; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SPINAL CORD ISCHEMIA; ANIMAL; ANIMAL MODEL; CHEMISTRY; GRAPE; ISOLATION AND PURIFICATION; MULBERRY;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; MODELS, ANIMAL; MORUS; PLANT EXTRACTS; REPERFUSION INJURY; STILBENES; VITIS;

EID: 34047214017     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Soleas GJ, Diamandis EP and Goldberg DM: Resveratrol: a molecule whose time has come and gone? Clin Biochem 30: 91-113, 1997.
2. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M and Arichi S: Effects of stilbene components of the roots of polygonium on lipid metabolism. Chem Pharm Bull 30: 1766-1770, 1982.
3. Belguendouz L, Fremont L and Linard A: Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 53: 1347-1355, 1997.
4. Frankel EN, Waterhouse AL and Kinsella JE: Inhibition of human LDL oxidation by resveratrol. Lancet 34: 1103-1104, 1993.
5. Lu R and Serrero G: Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179: 297-304, 1999.
6. Chun YJ, Kim MY and Guengerich FP: Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Comm 262: 20-24, 1999.
7. Clement MV, Hirpara JL, Chawdhury SH, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, trigger CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998.
8. Fontecave M, Lepoivre M, Elleingand E, Gerez C and Guittet O: Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421: 277-279, 1998.
9. Huang C, Ma WY, Goranson A and Dong Z: Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242, 1999.
10. Maccarrone M, Lorenzon T, Guerrieri P and Agro AF: Resveratrol prevents apoptosis in K562 cells by inhibiting lipooxygenase and cyclooxygenase activity. Eur J Biochem 265: 27-34, 1999.
11. Miloso M, Bertelli AAE, Nicolini G and Tredici G: Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci Lett 264: 141-144, 1999.
12. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, Seiler N and Raul F: Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 158: 85-91, 2000.
13. She QB, Bode AM, Ma WY, Chen NY and Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604-1610, 2001.
14. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM and Dannenberg AJ: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273: 21875-21882, 1998.
15. Sun NJ, Woo SH, Cassady JM and Snapka RM: DNA polymerase and topoisomerase II inhibitors form Psoralea corylifolia. J Natl Prod 61: 362-366, 1998.
16. Zou J, Huang Y, Chen Q, Wang N, Cao K, Hsieh TC and Wu JM: Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultures smooth muscle cells. Int J Oncol 15: 647-651, 1999.
17. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S and Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840, 2004.
18. Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH and Han Z: The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res 24: 999-1002, 2004.
19. Chen Y, Tseng SH, Lai HS and Chen WJ: Resveratrol-induced cellular apoptosis and cell cycle arrest of in neuroblastoma cells and exerted antitumor effects on neuroblastoma in mice. Surgery 136: 57-66, 2004.
20. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghom AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
21. Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER and Reddy GPV: Resveratrol induces prostate cancer cell line entry into S phase and inhibits DNA synthesis. Cancer Res 62: 2488-2492, 2002.
22. Liontas A and Yeger H: Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24: 987-998, 2004.
23. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G and Lee SJ: Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 140: 1-10, 1999.
24. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY and Chen Y: Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202, 2004.
25. Uenobe F, Nakamura S and Miyazawa M: Antimutagenic effect of resveratrol against Trp-P1. Mutat Res 373: 197-200, 1997.
26. Dulak J: Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol 56(Suppl 1): 51-69, 2005.
27. V integrins. Science 270: 1500-1502, 1995.
28. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB and Piantelli M: Flavonoid apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87: 595-600, 2000.
29. D'Amore PA and Thompson RW: Mechanisms of angiogenesis. Annu Rev Physiol 49: 453-464, 1987.
30. Folkman J and Klagsburn M: Angiogenic factors. Science 235: 442-447, 1987.
31. Cheresh DA: Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84: 6471-6475, 1987.
32. 1 and by platelet-derived growth factor-BB. J Cell Physiol 151: 588-595, 1992.
33. Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J and Antoniades HN: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51: 1345-1351, 1991.
34. Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. J Natl Cancer Inst 143: 401-409, 1993.
35. Weidner N, Folkman J, Pozza F, Bevilaoqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 84: 1875-1887, 1992.
36. Bradamante S, Piccinini F, Barenghi L, Bertelli AA, de Jonge R, Beemster P and de Jong JW: Does resveratrol induce pharmacological preconditioning? Int J Tissue Reactions 22: 1-4, 2000.
37. Chander V and Chopra K: Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 42: 1198-1205, 2005.
38. Hascalik S, Celik O, Turkoz Y, Hascalik M, Cigremis Y, Mizrak B and Yologlu S: Resveratrol, a red wine constituent ployphenol, protects from ischemia-reperfusion damage of the ovaries. Gynecol Obstet Invest 57: 218-223, 2004.
39. Hung LM, Chen JK, Huang SS, Lee RS and Su MJ: cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Res 47: 549-555, 2000.
40. Kaga S, Zhan L, Matsumoto M and Maulik N: Resveratrol enhances neovascularization in the infracted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39: 813-822, 2005.
41. Kiziltepe U, Turan NN, Han U, Ulus AT and Akar F: Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vascular Surg 40: 138-145, 2004.
42. Ray PS, Maulik G, Cordis GA, Bertelli AAE, Bertelli A and Das DK: The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biol Med 27: 160-169, 1999.
43. Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A and Das DK: Myocardial protection with red wine extract. J Cardiovascular Pharmacol 35: 263-268, 2000.
44. Wang O, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY and Sun AY: Resveratrol protects against global ischemic injury in gerbils. Brain Res 958: 439-447, 2002.
45. Zhuang H, Kim YS, Koehler RC and Dore S: Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann New York Acad Sci 993: 276-288, 2003.
46. Hale SL and Kloner RA: Effects of resveratrol, a flavinoid found in red wine, on infarct size in an experimental model of ischemia/reperfusion. J Studies on Alcohol 62: 730-735, 2001.
47. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AAE, Panichi V, Filippi C and Bertelli A: Resveratrol, a polyphenol found a wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovascular Pharmacol 37: 262-270, 2001.
48. Virgili M and Contestabile A: Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett 281: 123-126, 2000.
49. Wang MJ, Huang HM, Hsieh SJ, Jeng KCG and Kuo JS: Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/ hypoglycemia followed by reoxygenation. J Neuroimmunol 112: 28-34, 2001.
50. Ahmad KA, Clement MV and Pervaiz S: Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann New York Acad Sci 1010: 365-373, 2003.
51. Bertelli AA, Mogliori M, Panichi V, Origlia N, Filippi C, Das DK and Giovannini L: Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann New York Acad Sci 957: 230-238, 2002.
52. Hung LM, Su MJ, Chu WK et al: The protective effect of resveratrol on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Brit J Pharmacol 135: 1627-1633, 2002.
53. Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T and Korthuis RJ: Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/ reperfusion, platelet-activating factor, or oxidants. Free Rad Biol Med 34: 810-817, 2003.
54. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG and Huang YZ: Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8: 3-17, 2001.
55. Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A and Maulik N: Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44: 43-49, 2006.
56. Luque Contreras D, Vargas Robles H, Romo E, Rios A and Escalante B: The role of nitric oxide in the post-ischemix revascularization process. Pharmacol Ther 112: 553-563, 2006.
57. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K and Forstermann U: Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106: 1652-1658, 2002.
58. Brakenhielm E, Cao R and Cao Y: Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15: 1798-1800, 2001.
59. Chen JC, Chen Y, Lin JH, Wu JM and Tseng SH: Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer Res 26(2A): 1237-1245, 2006.
60. Garvin S, Ollinger K and Dabrosin C: Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231: 113-122, 2006.
61. Hsieh TC and Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 249: 109-115, 1999.
62. Igura K, Ohta T, Kuroda Y and Kaji K: Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171: 11-16, 2001.
63. Kimura Y and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849, 2001.
64. Poussier B, Cordova AC, Becquemin JP and Sumpio BE: Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 42: 1190-1197, 2005.
65. Mousa SS, Mousa SS and Mousa SA: Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52: 59-65, 2005.
66. Cao Z, Fang J, Xia C, Shi X and Jiang BH: Trans-3,4,5′-trihydroxystilbene inhibits hypoxia-inducible factor 1α and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 10: 5253-5263, 2004.
67. Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, Kang KS, Lu J and Kim SH: Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27: 2059-2069, 2006.
68. Cao Y, Fu ZD, Wang F, Liu HY and Han R: Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 7: 205-213, 2005.
69. Oak MH, El Bedoui J and Schini-Kerth VB: Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16: 1-8, 2005.
70. Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506, 2006.
71. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP and Ducharma MP: Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302: 369-373, 2002.
72. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382, 2004.
73. Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP and Gescher AJ: Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br J Cancer 90: 736-744, 2004.
74. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72: 2219-2233, 2003.